271 related articles for article (PubMed ID: 33253355)
1. Brain cancer induces systemic immunosuppression through release of non-steroid soluble mediators.
Ayasoufi K; Pfaller CK; Evgin L; Khadka RH; Tritz ZP; Goddery EN; Fain CE; Yokanovich LT; Himes BT; Jin F; Zheng J; Schuelke MR; Hansen MJ; Tung W; Parney IF; Pease LR; Vile RG; Johnson AJ
Brain; 2020 Dec; 143(12):3629-3652. PubMed ID: 33253355
[TBL] [Abstract][Full Text] [Related]
2. Progression of intracranial glioma disrupts thymic homeostasis and induces T-cell apoptosis in vivo.
Andaloussi AE; Han Y; Lesniak MS
Cancer Immunol Immunother; 2008 Dec; 57(12):1807-16. PubMed ID: 18392618
[TBL] [Abstract][Full Text] [Related]
3. Synergy between the ectoenzymes CD39 and CD73 contributes to adenosinergic immunosuppression in human malignant gliomas.
Xu S; Shao QQ; Sun JT; Yang N; Xie Q; Wang DH; Huang QB; Huang B; Wang XY; Li XG; Qu X
Neuro Oncol; 2013 Sep; 15(9):1160-72. PubMed ID: 23737488
[TBL] [Abstract][Full Text] [Related]
4. Increasing glioma-associated monocytes leads to increased intratumoral and systemic myeloid-derived suppressor cells in a murine model.
Chae M; Peterson TE; Balgeman A; Chen S; Zhang L; Renner DN; Johnson AJ; Parney IF
Neuro Oncol; 2015 Jul; 17(7):978-91. PubMed ID: 25537019
[TBL] [Abstract][Full Text] [Related]
5. Characterization of thymic involution induced by murine cytomegalovirus infection.
Price P; Olver SD; Gibbons AE; Teo HK; Shellam GR
Immunol Cell Biol; 1993 Jun; 71 ( Pt 3)():155-65. PubMed ID: 7688711
[TBL] [Abstract][Full Text] [Related]
6. Glioblastoma-Derived IL6 Induces Immunosuppressive Peripheral Myeloid Cell PD-L1 and Promotes Tumor Growth.
Lamano JB; Lamano JB; Li YD; DiDomenico JD; Choy W; Veliceasa D; Oyon DE; Fakurnejad S; Ampie L; Kesavabhotla K; Kaur R; Kaur G; Biyashev D; Unruh DJ; Horbinski CM; James CD; Parsa AT; Bloch O
Clin Cancer Res; 2019 Jun; 25(12):3643-3657. PubMed ID: 30824583
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-10 promotes B16-melanoma growth by inhibition of macrophage functions and induction of tumour and vascular cell proliferation.
García-Hernández ML; Hernández-Pando R; Gariglio P; Berumen J
Immunology; 2002 Feb; 105(2):231-43. PubMed ID: 11872099
[TBL] [Abstract][Full Text] [Related]
8. TREM2 mediates MHCII-associated CD4+ T-cell response against gliomas.
Zheng J; Wang L; Zhao S; Zhang W; Chang Y; Bosco DB; Huang T; Dheer A; Gao S; Xu S; Ayasoufi K; Al-Kharboosh R; Qi F; Xie M; Johnson AJ; Dong H; Quiñones-Hinojosa A; Wu LJ
Neuro Oncol; 2024 May; 26(5):811-825. PubMed ID: 37941134
[TBL] [Abstract][Full Text] [Related]
9. Altered aging-related thymic involution in T cell receptor transgenic, MHC-deficient, and CD4-deficient mice.
Lau LL; Spain LM
Mech Ageing Dev; 2000 Mar; 114(2):101-21. PubMed ID: 10799708
[TBL] [Abstract][Full Text] [Related]
10. miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma.
Wei J; Wang F; Kong LY; Xu S; Doucette T; Ferguson SD; Yang Y; McEnery K; Jethwa K; Gjyshi O; Qiao W; Levine NB; Lang FF; Rao G; Fuller GN; Calin GA; Heimberger AB
Cancer Res; 2013 Jul; 73(13):3913-26. PubMed ID: 23636127
[TBL] [Abstract][Full Text] [Related]
11. Defective thymic progenitor development and mature T-cell responses in a mouse model for Down syndrome.
Lorenzo LP; Shatynski KE; Clark S; Yarowsky PJ; Williams MS
Immunology; 2013 Aug; 139(4):447-58. PubMed ID: 23432468
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-23-expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma.
Yuan X; Hu J; Belladonna ML; Black KL; Yu JS
Cancer Res; 2006 Mar; 66(5):2630-8. PubMed ID: 16510582
[TBL] [Abstract][Full Text] [Related]
13. Enhanced immunosuppression by therapy-exposed glioblastoma multiforme tumor cells.
Authier A; Farrand KJ; Broadley KW; Ancelet LR; Hunn MK; Stone S; McConnell MJ; Hermans IF
Int J Cancer; 2015 Jun; 136(11):2566-78. PubMed ID: 25363661
[TBL] [Abstract][Full Text] [Related]
14. Systemic T Cells Immunosuppression of Glioma Stem Cell-Derived Exosomes Is Mediated by Monocytic Myeloid-Derived Suppressor Cells.
Domenis R; Cesselli D; Toffoletto B; Bourkoula E; Caponnetto F; Manini I; Beltrami AP; Ius T; Skrap M; Di Loreto C; Gri G
PLoS One; 2017; 12(1):e0169932. PubMed ID: 28107450
[TBL] [Abstract][Full Text] [Related]
15. FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas.
Yan J; Kong LY; Hu J; Gabrusiewicz K; Dibra D; Xia X; Heimberger AB; Li S
J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 25971300
[TBL] [Abstract][Full Text] [Related]
16. Thymic function and output of recent thymic emigrant T cells during intracranial glioma progression.
Prins RM; Graf MR; Merchant RE; Black KL; Wheeler CJ
J Neurooncol; 2003; 64(1-2):45-54. PubMed ID: 12952285
[TBL] [Abstract][Full Text] [Related]
17. Circulating immunoglobulin-bound transforming growth factor beta at a late tumour-bearing stage impairs antigen-specific responses of CD4+ T cells.
Harada M; Tatsugami K; Nomoto M; Nomoto K
Clin Exp Immunol; 2002 May; 128(2):204-12. PubMed ID: 12041507
[TBL] [Abstract][Full Text] [Related]
18. Hemagglutinating virus of Japan-envelope containing programmed cell death-ligand 1 siRNA inhibits immunosuppressive activities and elicits antitumor immune responses in glioma.
Sugii N; Matsuda M; Okumura G; Shibuya A; Ishikawa E; Kaneda Y; Matsumura A
Cancer Sci; 2021 Jan; 112(1):81-90. PubMed ID: 33155337
[TBL] [Abstract][Full Text] [Related]
19. Non-myeloablative busulfan chimeric mouse models are less pro-inflammatory than head-shielded irradiation for studying immune cell interactions in brain tumours.
Youshani AS; Rowlston S; O'Leary C; Forte G; Parker H; Liao A; Telfer B; Williams K; Kamaly-Asl ID; Bigger BW
J Neuroinflammation; 2019 Feb; 16(1):25. PubMed ID: 30722781
[TBL] [Abstract][Full Text] [Related]
20. In vivo treatment of class II MHC-deficient mice with anti-TCR antibody restores the generation of circulating CD4 T cells and optimal architecture of thymic medulla.
Nasreen M; Ueno T; Saito F; Takahama Y
J Immunol; 2003 Oct; 171(7):3394-400. PubMed ID: 14500633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
